Plott Ronald Todd Insider Profile
4 Followers
Plott Ronald Todd, Director at Phio Pharmaceuticals, holds 15.00K shares in Phio Pharmaceuticals (Ticker: PHIO), holds ― shares in Timber Pharmaceuticals (Ticker: TMBRQ). Most recently, Plott Ronald Todd Bought ― shares of Phio Pharmaceuticals on Aug 20, 2026 for an estimated value of $17.10K.
Plott Ronald Todd has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Plott Ronald Todd's holdings
Insider Roles
Director
Roles that Plott Ronald Todd holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Plott Ronald Todd
Plott Ronald Todd's Trading History
Phio Pharmaceuticals
Aug 20, 2026
Director
Informative Buy
17.10K
$16.95K
Timber Pharmaceuticals
―
―
―
―
List of latest transactions for each holding click on a transaction to see Plott Ronald Todd's performance on stock
You May Also Like
Plott Ronald Todd insider profile FAQ
What is the percentage of profitable transactions made by Plott Ronald Todd?
The percentage of profitable transactions made by Plott Ronald Todd is ―.
What is the average return per transaction made by Plott Ronald Todd?
The average return per transaction made by Plott Ronald Todd is ―.
What stocks does Plott Ronald Todd hold?
Plott Ronald Todd holds: PHIO, TMBRQ stocks.
What was Plott Ronald Todd’s latest transaction?
Plott Ronald Todd latest transaction was an Informative Buy of $17.10K.
What was Plott Ronald Todd's most profitable transaction?
Plott Ronald Todd’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Plott Ronald Todd's role in Phio Pharmaceuticals?
Plott Ronald Todd's role in Phio Pharmaceuticals is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.